Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016–2019

[1]  M. Maheu-Giroux,et al.  Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l’Actuel PrEP Cohort (2013–2020) , 2022, Sexually Transmitted Infections.

[2]  S. Banhart,et al.  Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  William R Truong,et al.  The antibiogram: key considerations for its development and utilization , 2021, JAC-antimicrobial resistance.

[4]  K. Looker,et al.  Chemsex and diagnoses of syphilis, gonorrhoea and chlamydia among men who have sex with men in the UK: a multivariable prediction model using causal inference methodology , 2021, Sexually Transmitted Infections.

[5]  M. Unemo,et al.  2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. , 2020, International journal of STD & AIDS.

[6]  T. Pumarola,et al.  Antimicrobial susceptibility of Neisseria gonorrhoeae in Barcelona during a five-year period, 2013 to 2017 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  R. Kirkcaldy,et al.  Epidemiology of gonorrhoea: a global perspective. , 2019, Sexual health.

[8]  I. Martin,et al.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. , 2019, Sexual health.

[9]  C. Hoebe,et al.  Chemsex among men who have sex with men living outside major cities and associations with sexually transmitted infections: A cross-sectional study in the Netherlands , 2019, PloS one.

[10]  F. Cobo,et al.  Typing and antimicrobial susceptibility of 134 Neisseria gonorrhoeae strains from Southern Spain , 2019, Revista Española de Quimioterapia.

[11]  P. V. Van Caeseele,et al.  Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012-2016. , 2019, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[12]  Raquel Abad,et al.  Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey , 2018, The Lancet. Infectious diseases.

[13]  Xavier Didelot,et al.  Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study , 2017, PLoS medicine.

[14]  X. Didelot,et al.  Quantifying the fitness benefit and cost of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy , 2017, bioRxiv.

[15]  C. Garriga,et al.  Gonorrhoea diagnoses in a network of STI clinics in Spain during the period 2006–2010: differences by sex and transmission route , 2013, BMC Public Health.

[16]  D. Livermore,et al.  Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. , 2013, The Lancet. Infectious diseases.

[17]  M. Unemo,et al.  Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae , 2009, Expert review of anti-infective therapy.

[18]  J. Zenilman,et al.  Gonorrhea Reinfection Among Sexually Transmitted Disease Clinic Attendees in Baltimore, Maryland , 2006, Sexually transmitted diseases.

[19]  W. Levine,et al.  Gonorrhea Prevalence and Coinfection With Chlamydia in Women in the United States, 2000 , 2003, Sexually transmitted diseases.

[20]  J. López de Munain.  Epidemiology and current control of sexually transmitted infections. The role of STI clinics. , 2019, Enfermedades infecciosas y microbiologia clinica.

[21]  J. López de Munain,et al.  Epidemiology and current control of sexually transmitted infections. The role of STI clinics. , 2019, Enfermedades infecciosas y microbiologia clinica.

[22]  F. Denmark,et al.  Women in the United States , 2017 .

[23]  G. Spiteri,et al.  Gonococcal antimicrobial susceptibility surveillance in Europe 2010. , 2012 .

[24]  Jeffrey F Peipert,et al.  Clinical practice. Genital chlamydial infections. , 2003, The New England journal of medicine.